Monday, September 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Defense Contracts Provide Ballast for Boeing Amid Commercial Turbulence

SiterGedge by SiterGedge
March 14, 2026
in Analysis, Defense & Aerospace, Industrial
0
Boeing Stock
0
SHARES
40
VIEWS
Share on FacebookShare on Twitter

Boeing shares advanced more than two percent on Friday, buoyed by a pair of significant defense contracts from the U.S. Department of Defense. This support from the company’s military division arrives as its commercial airplane unit continues to grapple with persistent manufacturing challenges.

A Closer Look at the New Awards

The larger of the two agreements is a contract modification from the U.S. Air Force valued at $2.43 billion. This funding is allocated for the continued development of the E-7A Wedgetail, an airborne early warning and control aircraft built on the 737 platform. With this latest award, the total value of the E-7A program rises to approximately $4.9 billion. Work under this contract is scheduled for completion by August 2032.

In a separate transaction, Boeing secured an additional $289 million order to supply precision-guided bombs to Israel. The combined value of these defense deals appears to have outweighed ongoing concerns in the market regarding Boeing’s civil aviation segment.

Should investors sell immediately? Or is it worth buying Boeing?

Persistent Headwinds in Commercial Aviation

Meanwhile, regulatory and production issues continue to pressure Boeing’s commercial airplane business. On March 12, the Federal Aviation Administration (FAA) proposed a new Airworthiness Directive. This directive would mandate inspections of 787 Dreamliner aircraft for potential fatigue cracking resulting from manufacturing flaws.

Concurrently, the company has temporarily halted deliveries of some 737 MAX jets. This pause stems from a wiring configuration issue discovered in early March, which requires rework on undelivered airplanes. Boeing has stated that aircraft already in service do not face an immediate safety risk from this issue. Despite these delays, the aerospace giant maintains it will still meet its annual delivery targets for the year.

Market Perception and the Path Forward

For now, the multi-billion dollar influx from the defense sector is dominating market sentiment, offsetting the negative news flow from production setbacks. Whether this balance holds depends significantly on Boeing’s ability to swiftly stabilize its 737 MAX production line. The company’s broader financial recovery is closely tied to this crucial factor, as it works to restore confidence and operational consistency in its flagship commercial program.

Ad

Boeing Stock: Buy or Sell?! New Boeing Analysis from September 21 delivers the answer:

The latest Boeing figures speak for themselves: Urgent action needed for Boeing investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 21.

Boeing: Buy or sell? Read more here...

Tags: Boeing
SiterGedge

SiterGedge

Related Posts

Rheinmetall Stock
DAX

Rheinmetall’s Order Book Pushes Past €80 Billion as New Shell Deal Lands

September 14, 2026
Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
Almonty Stock
Asian Markets

Almonty’s Double Play: A $300 Million Buyback Lands as Sangdong’s Stockpile Grows

September 7, 2026
Next Post
Johnson & Johnson Stock

Johnson & Johnson Strengthens Healthcare Portfolio with Dual Clinical Advancements

XPeng Stock

XPeng's Strategic Momentum: Partnerships and Tech Drive European Ambitions

Anavex Stock

Anavex Shares Gain on Promising Clinical Data for Alzheimer's Candidate

Recommended

Beyond Meat Stock

Beyond Meat Shares Surge in Meme-Stock Frenzy

11 months ago
iShares Global Clean Energy ETF Stock

The Hidden Concentration Risk in Clean Energy Investing

11 months ago
Solana Stock

Solana ETF Approval Looms as Regulatory Deadline Approaches

12 months ago
Macom Stock

M/A-COM Technology Shares Enter Expected Consolidation Phase

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Tokenization’s Green Light: Crypto Rallies Where Congress Stalled

5% Money Forces AI’s Believers to Show Their Math

Software Sends AI’s First Real Invoice as Yields Break 5%

Rheinmetall’s Order Book Pushes Past €80 Billion as New Shell Deal Lands

AI’s Warning Lights Flash as Crypto Steals the Spotlight

Oracle’s Backlog Defies the Bond Market While Crypto Bends

Trending

Morgan Stanley Stock
Newsletter

AI’s Next Bottleneck Isn’t Chips. It’s Cybersecurity.

by Stephanie Dugan
September 21, 2026
0

Dear readers, Yesterday we wrote about a market forced to separate cash machines from cash burners now...

Amazon Stock

Five Percent Yields Separate Cash Machines From Cash Burners

September 19, 2026
Coinbase Stock

Real Assets, Real Cash Flows: Wall Street’s Post-Hike Rotation

September 18, 2026
Coinbase Stock

Tokenization’s Green Light: Crypto Rallies Where Congress Stalled

September 17, 2026
Nvidia Stock

5% Money Forces AI’s Believers to Show Their Math

September 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AI’s Next Bottleneck Isn’t Chips. It’s Cybersecurity.
  • Five Percent Yields Separate Cash Machines From Cash Burners
  • Real Assets, Real Cash Flows: Wall Street’s Post-Hike Rotation

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com